OBJECTIVE: To detect and quantify peripheral nerve lesions in multiple sclerosis (MS) by magnetic resonance neurography (MRN). METHODS: Thirty-six patients diagnosed with MS based on the 2010 McDonald criteria (34 with the relapsing-remitting form, 2 with clinically isolated syndrome) with and without disease-modifying treatment were compared to 35 healthy age-/sex-matched volunteers. All patients underwent detailed neurological and electrophysiological examinations. Three Tesla MRN with large anatomical coverage of both legs and the lumbosacral plexus was performed by using 2-dimensional (2D) fat-saturated, T2-weighted (T2w) and dual echo turbo spin echo sequences as well as a 3D T2-weighted, fat-saturated SPACE sequence. Besides qualitative visual nerve assessment, a T2w signal quantification was performed by calculation of proton spin density and T2 relaxation time. Nerve diameter was measured as a morphometric criterion. RESULTS: T2w hyperintense nerve lesions were detectable in all MS patients, with a mean lesion number at thigh level of 151.5 ± 5.7 versus 19.1 ± 2.4 in controls (p < 0.0001). Nerve proton spin density was higher in MS (tibial/peroneal: 371.8 ± 7.7/368.9 ± 8.2) versus controls (tibial/peroneal: 266.0 ± 11.0/276.8 ± 9.7, p < 0.0001). In contrast, T2 relaxation time was significantly higher in controls (tibial/peroneal: 82.0 ± 2.1/78.3 ± 1.7) versus MS (tibial/peroneal: 64.3 ± 1.0/61.2 ± 0.9, p < 0.0001). Proximal tibial and peroneal nerve caliber was higher in MS (tibial: 52.4 ± 2.1mm2 , peroneal: 25.4 ± 1.3mm2 ) versus controls (tibial: 45.2 ± 1.4mm2 , p < 0.0015; peroneal: 21.3 ± 0.7mm2 , p = 0.0049). INTERPRETATION: Peripheral nerve lesions could be visualized and quantified in MS in vivo by high-resolution MRN. Lesions are defined by an increase of proton spin density and a decrease of T2 relaxation time, indicating changes in the microstructural organization of the extracellular matrix in peripheral nerve tissue in MS. By showing involvement of the peripheral nervous system in MS, this proof-of-concept study may offer new insights into the pathophysiology and treatment of MS. Ann Neurol 2017;82:676-685.
OBJECTIVE: To detect and quantify peripheral nerve lesions in multiple sclerosis (MS) by magnetic resonance neurography (MRN). METHODS: Thirty-six patients diagnosed with MS based on the 2010 McDonald criteria (34 with the relapsing-remitting form, 2 with clinically isolated syndrome) with and without disease-modifying treatment were compared to 35 healthy age-/sex-matched volunteers. All patients underwent detailed neurological and electrophysiological examinations. Three Tesla MRN with large anatomical coverage of both legs and the lumbosacral plexus was performed by using 2-dimensional (2D) fat-saturated, T2-weighted (T2w) and dual echo turbo spin echo sequences as well as a 3D T2-weighted, fat-saturated SPACE sequence. Besides qualitative visual nerve assessment, a T2w signal quantification was performed by calculation of proton spin density and T2 relaxation time. Nerve diameter was measured as a morphometric criterion. RESULTS: T2w hyperintense nerve lesions were detectable in all MS patients, with a mean lesion number at thigh level of 151.5 ± 5.7 versus 19.1 ± 2.4 in controls (p < 0.0001). Nerve proton spin density was higher in MS (tibial/peroneal: 371.8 ± 7.7/368.9 ± 8.2) versus controls (tibial/peroneal: 266.0 ± 11.0/276.8 ± 9.7, p < 0.0001). In contrast, T2 relaxation time was significantly higher in controls (tibial/peroneal: 82.0 ± 2.1/78.3 ± 1.7) versus MS (tibial/peroneal: 64.3 ± 1.0/61.2 ± 0.9, p < 0.0001). Proximal tibial and peroneal nerve caliber was higher in MS (tibial: 52.4 ± 2.1mm2 , peroneal: 25.4 ± 1.3mm2 ) versus controls (tibial: 45.2 ± 1.4mm2 , p < 0.0015; peroneal: 21.3 ± 0.7mm2 , p = 0.0049). INTERPRETATION: Peripheral nerve lesions could be visualized and quantified in MS in vivo by high-resolution MRN. Lesions are defined by an increase of proton spin density and a decrease of T2 relaxation time, indicating changes in the microstructural organization of the extracellular matrix in peripheral nerve tissue in MS. By showing involvement of the peripheral nervous system in MS, this proof-of-concept study may offer new insights into the pathophysiology and treatment of MS. Ann Neurol 2017;82:676-685.
Authors: S Weiner; M Strinitz; J Herfurth; F Hessenauer; C Nauroth-Kreß; T Kampf; G A Homola; N Üçeyler; C Sommer; M Pham; M Schindehütte Journal: AJNR Am J Neuroradiol Date: 2022-04-21 Impact factor: 3.825
Authors: Adriana M Pietsch; Andrea Viehöver; Ricarda Diem; Markus Weiler; Mirjam Korporal-Kuhnke; Brigitte Wildemann; Georges Sam; John M Hayes; Olivia Fösleitner; Johann M E Jende; Sabine Heiland; Martin Bendszus; Jennifer C Hayes Journal: Clin Neuroradiol Date: 2022-10-20 Impact factor: 3.156
Authors: Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek Journal: Clin Auton Res Date: 2018-09-12 Impact factor: 4.435
Authors: Valentina Pegoretti; Kathryn A Swanson; John R Bethea; Lesley Probert; Ulrich L M Eisel; Roman Fischer Journal: Oxid Med Cell Longev Date: 2020-05-12 Impact factor: 6.543
Authors: Johann M E Jende; Jan B Groener; Christian Rother; Zoltan Kender; Artur Hahn; Tim Hilgenfeld; Alexander Juerchott; Fabian Preisner; Sabine Heiland; Stefan Kopf; Mirko Pham; Peter Nawroth; Martin Bendszus; Felix T Kurz Journal: JAMA Netw Open Date: 2019-05-03
Authors: Yavor Yalachkov; Valerie Uhlmann; Johannes Bergmann; Dilara Soydaş; Stefan Frisch; Marion Behrens; Christian Foerch; Johannes Gehrig Journal: PLoS One Date: 2020-02-04 Impact factor: 3.240
Authors: Michael Pridmore; Ryan Castoro; Megan Simmons McCollum; Hakmook Kang; Jun Li; Richard Dortch Journal: Ann Clin Transl Neurol Date: 2019-12-24 Impact factor: 4.511
Authors: Jennifer Kollmer; Ute Hegenbart; Christoph Kimmich; Ernst Hund; Jan C Purrucker; John M Hayes; Stephen I Lentz; Georges Sam; Johann M E Jende; Stefan O Schönland; Martin Bendszus; Sabine Heiland; Markus Weiler Journal: Ann Clin Transl Neurol Date: 2020-04-25 Impact factor: 4.511